Core Insights - Talkspace is experiencing accelerating growth in its payer-focused model, with a strategic pivot from consumer services to a payer fee-for-service model that has reshaped its financial results [5][6] Financial Performance - For full-year 2025, Talkspace reported approximately $229 million in revenue, a 22% year-over-year increase, driven by a 38% growth in payer revenue [4] - The company achieved an adjusted EBITDA of $15.8 million, more than doubling from about $7 million in 2024, resulting in a 7% adjusted EBITDA margin [4] - Fourth quarter revenue reached $63.0 million, up 29.3% year-over-year, with payer revenue at $47.7 million, a 41% increase [14] - Gross profit was $26.9 million, reflecting a 24.4% increase, with a gross margin of 42.7% [16] Growth Initiatives - Talkspace has expanded its payer partnerships, now covering over 200 million lives through insurance and employer benefits, supported by initiatives to increase awareness and drive high-intent referrals [3][5] - The company is investing in AI-driven product initiatives, including the development of a specialized mental health support AI, the Talk AI agent, which is currently in beta testing [12][13] Product and Service Expansion - Talkspace is enhancing its service offerings, including the acquisition of Wisdo, an AI-powered social health platform, and the launch of TeenSpace, a program aimed at youth mental health [7][8] - The company is also focusing on directory integrations and improving the member journey to increase utilization [2][6] Market Outlook - For 2026, Talkspace expects revenue to grow, with payer revenue growth anticipated to align with 2025 rates, while consumer revenue is expected to decline intentionally [17] - Initial guidance for 2026 projects revenue between $275 million to $290 million, representing a year-over-year growth of 20% to 27% [19]

Financial Data and Key Metrics Changes - For the full year of 2025, the company reported revenue of approximately $229 million, a 22% year-over-year increase, driven by payer growth of 38% [5] - Adjusted EBITDA more than doubled, growing from about $7 million in 2024 to $15.8 million in 2025, representing an adjusted EBITDA margin of 7% [5] - In Q4, total revenue was $63.0 million, a 29.3% year-over-year increase, with payer business revenue at $47.7 million, up 41% year-over-year [17] - Adjusted EBITDA for Q4 was $6.6 million, representing a 147.1% year-over-year growth, with an adjusted EBITDA margin of 10.4% [19] Business Line Data and Key Metrics Changes - The payer business was the primary growth driver, with session volume increasing by 36.3% year-over-year, totaling 450,000 sessions in Q4 [17] - Unique active payer members increased by 29.7% year-over-year to 124,000 [17] - Consumer revenue was $3.7 million, down 30.4% year-over-year, reflecting a strategic shift towards enterprise and payer channels [18] Market Data and Key Metrics Changes - The company now covers over 200 million lives through insurance and employer benefits, with significant growth in military and Medicare enrollment [5][9] - The TeenSpace program in New York City has enrolled over 45,000 teens, with 66% showing measurable clinical improvement [10] Company Strategy and Development Direction - The company is shifting from a consumer model to a payer fee-for-service model, focusing on strategic initiatives to increase awareness and drive referrals [4] - Expansion of offerings within the payer channel includes investments in psychiatry and the acquisition of Wisdo, aimed at catering to new populations [9] - The company is also developing a specialized AI agent for mental health support, which is expected to launch in late Q2 2026 [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's capability to continue growing and expanding profitability, with strong momentum observed in early 2026 [16] - The company anticipates revenue growth in 2026 to be between $275 million and $290 million, representing a year-over-year growth of 20%-27% [20] - Management noted that the payer business provides high visibility and retention, contributing to confidence in revenue projections [22] Other Important Information - The company has seen a significant reduction in marketing spending while increasing brand recognition through successful awareness campaigns [7] - The integration of Talkspace with Amazon Pharmacy has improved the patient experience by simplifying medication management [11] Q&A Session Summary Question: Challenges in transitioning users from general-purpose LLMs to Talkspace's LLM - Management acknowledged that it is early in the beta testing phase and emphasized the importance of security and safety in their offering [25][26] Question: Clarification on revenue guidance and new member acquisition - Management clarified that a significant portion of payer revenue will come from existing members, but they will also drive new user acquisition through marketing and directory integrations [29][31] Question: Directory integrations and their impact on utilization - Management indicated plans for at least three additional directory integrations in early 2026, which are expected to enhance user experience and conversion rates [35][36] Question: Medicare Advantage opportunities and participation in access programs - Management confirmed their intention to participate in the Medicare access program and expressed confidence in growth within the Medicare segment [39][40] Question: Insights on early momentum in 2026 - Management noted that early indicators show continued momentum in user engagement and session bookings as the year begins [44][46] Question: Behavioral health costs and payer conversations - Management discussed the rising costs of behavioral health care and emphasized the value of mental health support in reducing overall healthcare expenses [48][50] Question: Revenue contribution from Wisdo and inorganic growth - Management indicated that Wisdo's contribution to revenue in 2026 is expected to be modest, primarily embedded within existing business lines [93] Question: Appetite for additional acquisitions - Management stated that they are well-positioned with current enhancements and acquisitions but remain open to exploring additional opportunities as needed [95]

Financial Data and Key Metrics Changes - For the full year of 2025, the company reported revenue of approximately $229 million, a 22% year-over-year increase, driven by payer growth of 38% [5] - Adjusted EBITDA more than doubled, growing from about $7 million in 2024 to $15.8 million in 2025, representing an adjusted EBITDA margin of 7% [5] - In Q4, total revenue was $63.0 million, a 29.3% year-over-year increase, with payer business revenue at $47.7 million, up 41% year-over-year [17] - Adjusted EBITDA for Q4 was $6.6 million, representing a 147.1% year-over-year growth, with an adjusted EBITDA margin of 10.4%, up nearly 500 basis points versus the prior year [19] Business Line Data and Key Metrics Changes - The payer business continued to be the primary growth driver, with session volume increasing to 450,000 in Q4, a 36.3% year-over-year increase [17] - Unique active payer members for the quarter reached 124,000, representing a 29.7% year-over-year increase [17] - Consumer revenue was $3.7 million, down 30.4% year-over-year, consistent with the company's intentional prioritization of enterprise and payer channels [18] Market Data and Key Metrics Changes - The company now covers well over 200 million lives through insurance and employer benefits, with significant growth in military and Medicare enrollment [5][9] - The youth programs launched in major markets have shown strong measurable impact, with over 45,000 teens enrolled in the TeenSpace program in New York City alone [10] Company Strategy and Development Direction - The company has shifted from a consumer model to a payer fee-for-service model, focusing on strategic initiatives to increase awareness and drive high-intent referrals [4][5] - The integration of AI into the platform aims to improve patient journeys and provider workflows, with the Talk AI agent being developed for mental health support [15][16] - The company is expanding its offerings within the payer channel to cater to new populations and differing levels of acuity [5][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's capability and opportunity to continue growing the business and expanding profitability in 2026 [16] - The company anticipates revenue growth in 2026 to be in the range of $275 million to $290 million, representing 20%-27% year-over-year growth [20] - Management noted that the payer business brings a high degree of visibility and confidence in revenue modeling due to longer retention of payer members [22] Other Important Information - The company has invested in its psychiatry business and acquired Wisdo, an AI-powered social health platform, to enhance its service offerings [9] - The integration with Amazon Pharmacy allows members to fill prescriptions seamlessly, improving the patient experience [11] Q&A Session Summary Question: Challenges in transitioning users from general-purpose LLMs to Talk AI - Management acknowledged that it is early in the beta testing phase and emphasized the importance of security and safety in their offering [25][26] Question: Clarification on revenue guidance and new member acquisition - Management clarified that a material amount of payer revenue will come from existing members, but they will also drive new user acquisition through marketing and directory integrations [29][30] Question: Directory integrations and their impact - Management indicated that they are working on at least three additional directory integrations in early 2026, which are expected to be as significant as the first one [35][36] Question: Medicare Advantage opportunities - Management confirmed their interest in participating in the CMS access program and noted ongoing growth in Medicare enrollment [39][40] Question: Insights on early 2026 momentum - Management reported strong early engagement and session activity as indicators of continued momentum into 2026 [44][46] Question: Behavioral health costs and payer conversations - Management highlighted that increased engagement in mental health can save costs on the medical side and expressed confidence in their value-based contracts [49][50] Question: Revenue contribution from Wisdo - Management indicated that Wisdo's contribution to revenue in 2026 is expected to be modest, in the single-digit millions [93] Question: Appetite for additional acquisitions - Management stated they are well-positioned with current enhancements and acquisitions but remain open to exploring additional opportunities [95]

Financial Data and Key Metrics Changes - For the full year of 2025, the company reported revenue of approximately $229 million, a 22% year-over-year increase, driven by payer growth of 38% [4] - Adjusted EBITDA more than doubled, growing from about $7 million in 2024 to $15.8 million in 2025, representing an adjusted EBITDA margin of 7% [4] - In Q4 2025, total revenue was $63.0 million, a 29.3% year-over-year increase, with payer business revenue at $47.7 million, up 41% year-over-year [16] - Gross profit for Q4 was $26.9 million, resulting in a gross margin of 42.7%, down 169 basis points year-over-year [17] - Adjusted EBITDA for Q4 was $6.6 million, representing a 147.1% year-over-year growth, with an adjusted EBITDA margin of 10.4% [18] Business Line Data and Key Metrics Changes - The payer business was the primary growth driver, with session volume increasing by 36.3% year-over-year, totaling 450,000 sessions in Q4 [16] - Unique active payer members increased to 124,000, a 29.7% year-over-year increase [16] - Consumer revenue decreased by 30.4% year-over-year to $3.7 million, consistent with the company's strategic focus on enterprise and payer channels [17] Market Data and Key Metrics Changes - The company now covers over 200 million lives through insurance and employer benefits, with significant growth in military and Medicare enrollment [4][8] - The TeenSpace program in New York City has enrolled over 45,000 teens, with 66% showing measurable clinical improvement [9] Company Strategy and Development Direction - The company has shifted from a consumer model to a payer fee-for-service model, achieving a CAGR of 24% in revenue since 2022 [3] - Strategic initiatives include increasing awareness and driving high-intent referrals, as well as deepening partnerships with payers [4] - The company is expanding its offerings within the payer channel and investing in its psychiatry business [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's capability to continue growing and expanding profitability in 2026, supported by strong momentum observed early in the year [15] - The company is aware of rising healthcare costs but believes that increased engagement in mental health will ultimately save costs on the medical side [50] - Management is confident in their ability to participate in outcome-based models and has mechanisms in place to measure outcomes effectively [51] Other Important Information - The company is beta testing a new AI agent designed for mental health support, with plans to launch it publicly in late Q2 2026 [15][13] - The AI agent aims to extend the reach of clinicians while adhering to strict clinical standards [13] Q&A Session Summary Question: Challenges in transitioning users from general-purpose LLMs to Talkspace's LLM - Management acknowledged that it is early in the beta testing phase and emphasized the importance of security and safety in their offering [25][26] Question: Clarification on revenue guidance for 2026 - Management clarified that a significant portion of payer revenue will come from existing members on the platform, with ongoing efforts to drive new user acquisition [28][30] Question: Directory integrations and their impact - Management indicated plans for at least three additional directory integrations in early 2026, learning from the success of the first partner [33][35] Question: Opportunities within Medicare - Management confirmed their interest in participating in the Medicare access program and noted positive growth in their Medicare enrollment [37][39] Question: Insights on early momentum in 2026 - Management highlighted strong early engagement and re-engagement from users as a sign of continued momentum [44][46] Question: Behavioral health costs and payer conversations - Management noted that outpatient mental health services represent a small portion of overall healthcare spending and emphasized the value of their services in reducing overall costs [48][50] Question: Revenue contribution from Wisdo in 2026 - Management estimated a modest single-digit million contribution from Wisdo in 2026, embedded within existing business lines [94]

2025 Fourth Quarter Earnings Presentation February 19, 2026 2025 FOURTH QUARTER EARNINGS PRESENTATION 2 Disclaimer This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this presentation that do not relate to maers of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, ...

2025 First Quarter Earnings Presentation May 6, 2025 2025 FIRST QUARTER EARNINGS PRESENTATION 2 Disclaimer $64 54% $39 34% Revenue1 Composition USD, Millions PAYOR DTE CONSUMER Gross Profit and % Margin USD, Millions (1) Revenue is presented on an as-reported basis. This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this presentation that do not relate to maers of historical fact sh ...